Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF JULY 31, 2024 SAM #8282
SOLICITATION NOTICE

66 -- Azure 600 Imaging System

Notice Date

7/29/2024 5:50:58 PM
 

Notice Type

Combined Synopsis/Solicitation
 

NAICS

334516 — Analytical Laboratory Instrument Manufacturing
 

Contracting Office

FDA OFFICE OF ACQ GRANT SVCS Beltsville MD 20705 USA
 

ZIP Code

20705
 

Solicitation Number

75F40124Q00416
 

Response Due

8/9/2024 7:00:00 AM
 

Archive Date

08/24/2024
 

Point of Contact

PATRICIA NATIVIDAD, Phone: 3017968919
 

E-Mail Address

PATRICIA.NATIVIDAD@FDA.HHS.GOV
(PATRICIA.NATIVIDAD@FDA.HHS.GOV)
 

Small Business Set-Aside

SBA Total Small Business Set-Aside (FAR 19.5)
 

Description

This is a combined synopsis/solicitation for commercial services prepared in accordance with the format in FAR 12.6 and FAR 13 as supplemented and additional information included in this notice. The incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2024-05, effective 05/22/2024. THIS ANNOUNCEMENT CONSTITUTES THE ONLY SOLICITATION AND A SEPARATE SOLICITATION WILL NOT BE ISSUED.and Notice of intent to Sole Source. The solicitation number for this acquisition is 75F40124Q00416 and is being issued as a Request for Quote (RFQ). The NAICS Code for this solicitation is 334516 and the Small Business Size Standard is 1000 employees. This will be awarded as Firm-Fixed Price and completed as a Sole Source to Azure Biosystems.� Prospective Offerors are responsible for downloading the solicitation and any amendments from SAM.GOV. The Government reserves the right to award an order without discussions if the Contracting Officer determines that the initial offer is providing the Best Value and discussions are not necessary. The U.S. Food and Drug Administration (FDA) requires a Azure 600 Imaging System. BACKGROUND AND OVERVIEW Imager systems with chemiluminescence for Western blotting are integral tools in the FDA's efforts to protect public health. These systems provide high sensitivity and specificity in detecting and quantifying proteins, essential for quality control, drug development, medical device evaluation, and safety assessments. By leveraging advanced imaging technology, the FDA ensures that biological products and medical devices are safe, effective, and reliable See Attachment for the Solicitation CDER-2024-122015 07292024
 

Web Link

SAM.gov Permalink
(https://sam.gov/opp/91478b32ca284f7e9c1a785f4f348a59/view)
 

Place of Performance

Address: Silver Spring, MD 20993, USA

Zip Code: 20993

Country: USA
 

Record

SN07147376-F 20240731/240729230121 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |